$20.45
00.00%
Pre-Market: 4:00 PM EDT
Comments
Loading...
Bicara Therapeutics (NASDAQ:BCAX) Stock, Earnings Estimates, EPS, And Revenue
Bicara Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Nov 12
EPS
$-1.600
Quarterly Revenue
$0K
Annual Revenue
(as of Sep 30)
(as of Sep 30)
–
Analyze the earnings history of Bicara Therapeutics using advanced sorting and filters.
Data brought to you by Benzinga APIs
Bicara Therapeutics (BCAX) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
Bicara Therapeutics (BCAX) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Bicara Therapeutics (NASDAQ:BCAX) reporting earnings?
Bicara Therapeutics (BCAX) is scheduled to report earnings on February 16, 2025. The last reported earnings were for reported on November 12, 2024 for Q3.
What were the latest earnings per share (EPS) for Bicara Therapeutics (NASDAQ:BCAX)?
The Actual EPS was $-1.60, which missed the estimate of $0.00.
What were Bicara Therapeutics’s (NASDAQ:BCAX) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.